Ray Of Light : Malaria Rapid Tests
Malaria was a significant health risk across major geographical areas across the world. In 2020, nearly half of the world's population was at risk of malaria. Most cases and deaths arose across Sub-Saharan Africa. However, the WHO regions of south-east Asia, eastern Mediterranean, western pacific, and the Americas also report significant numbers of cases and deaths. The disease caused by parasites that are transmitted through bites of infected female anopheles mosquitoes are not contagious except in pregnancy. The incubation period for malaria is 14 - 30days.
Disease burden
Malaria is a preventable and curable disease. Early diagnosis and treatment of malaria reduces disease and prevents deaths, and also contributes to reducing transmissions. Antimalarial medicines can also be used to prevent malaria. Over the last 2 decades, expanded access to WHO-recommended malaria prevention tools and strategies – including effective vector control and the use of preventive antimalarial drugs – has had a major impact in reducing the global burden of this disease.
Vector control
Vector control is a vital component of malaria control and elimination strategies as it is highly effective in preventing infections and reducing disease transmission. WHO currently recommends either insecticide-treated nets (ITNs) or indoor residual spraying (IRS) for large-scale deployment in areas at risk of malaria. Supplementary interventions, such as larviciding, may be considered depending on context and resource availability.
Preventive chemotherapies
Preventive chemotherapy is the use of medicines, either alone or in combination, to prevent malaria infections and their consequences.
In 2020, 26 countries reported fewer than 100 indigenous cases of the disease, 6 countries up from 2000. Countries that have achieved at least 3 consecutive years of zero indigenous cases of malaria are eligible to apply for the WHO certification of malaria elimination. Over the last 2 decades, 11 countries have been certified by the WHO Director-General as Malaria-free.
Role of Biogenix in Global Prevention of Malaria:
Biogenix is one of India’s fastest emerging organization, setting a benchmark in In-Vitro Diagnostic (IVD) industry through its high quality accurate & responsive kits developed by highly qualified and experienced team for Research and Development. The commercial production takes place in a well-equipped, highly advanced automated plant established in Lucknow, Uttar Pradesh in the year 2017. During such short span Biogenix has followed all International norms and has been awarded with various National and International quality certifications like ISO, CE, and WHO/GMP etc. A constant process of Research and Development has allowed for more precise and improved Product quality to meet Indian as well as Global standards. Since its establishment, Biogenix has played a vital role in Screening and Prevention of Malaria through its Rapid Testing Kits for simultaneous detection and differentiation of Malaria Antigens.
Malaria Rapid Test Kit for Plasmodium falciparum antigen and P. Vivax antigen Detection
This test is a qualitative, lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of Plasmodium falciparum (Pf) and vivax (Pv) antigen in human blood specimen.
Malaria Rapid Test Kit for Plasmodium falciparum (Pf) antigen and Plasmodium antigen (PAN) species [P. vivax (Pv), P. ovale (Po), or P. malariae (Pm)] Detection
This test is a qualitative, lateral flow immunoassay for the detection and differentiation of P. falciparum specific histidine rich protein-2 (Pf. HRP-2) and Pan specific aldolase from human whole blood samples.
Today, the malarial parasite invades countries, cities and towns across the world. Effective control and prevention. Choosing the appropriate Malaria test will guarantee the effective control and treatment of malarial parasite.
Prompt and accurate diagnosis like that obtained from using a Malaria Rapid test, followed by effective treatment is currently the main Malaria control strategy. This is essential to prevent the disease, death and further transmission of Malaria.
Our Malaria Rapid Tests play a major role in areas with health clinics that need to perform on-site field testing, and are also preferred by community health workers in areas where malaria microscopy is not always immediately available.
And in addition, an ever increasing population travelling to various tropical regions also return with Malarial parasite infections.
Comparison with Other Technologies
However, comparing to other advanced testing methodologies, like ELISA, PCR etc., the rapid testing techniques might fall short in terms of pin point accurate results, but as the on-field testing demands count on effectiveness and reliability of the test in quick screening of the disease at point of care applications, plain testing procedures and sample requirements, the rapid tests pounce ahead by providing all of this, also in an affordable test format.
Biogenix is pleased to offer the Malaria Rapid Tests in two formats: Malaria Pf & Pv Rapid Test and Malaria Pf & PAN Rapid tests. Our kits are tested and approved by ICMR-NIMR and are available in cassette format only.
For information about any of these Rapid Tests, ELISA Test Kits, Clinical Chemistry Kits, Serology Kits, or any other testing kit products of interest, please contact:
info@biogenix.in | info@biogenixinc.com
The WHO African Region carries a disproportionately high share of the global malaria burden. In 2020, the region was home to 95% of malaria cases and 96% of malaria deaths. Children under 5 accounted for an estimated 80% of all malaria deaths in the Region.
Malaria is a preventable and curable disease. Early diagnosis and treatment of malaria reduces disease and prevents deaths, and also contributes to reducing transmissions. Antimalarial medicines can also be used to prevent malaria. Over the last 2 decades, expanded access to WHO-recommended malaria prevention tools and strategies – including effective vector control and the use of preventive antimalarial drugs – has had a major impact in reducing the global burden of this disease.
Vector control
Vector control is a vital component of malaria control and elimination strategies as it is highly effective in preventing infections and reducing disease transmission. WHO currently recommends either insecticide-treated nets (ITNs) or indoor residual spraying (IRS) for large-scale deployment in areas at risk of malaria. Supplementary interventions, such as larviciding, may be considered depending on context and resource availability.
Preventive chemotherapies
Preventive chemotherapy is the use of medicines, either alone or in combination, to prevent malaria infections and their consequences.
In 2020, 26 countries reported fewer than 100 indigenous cases of the disease, 6 countries up from 2000. Countries that have achieved at least 3 consecutive years of zero indigenous cases of malaria are eligible to apply for the WHO certification of malaria elimination. Over the last 2 decades, 11 countries have been certified by the WHO Director-General as Malaria-free.
Role of Biogenix in Global Prevention of Malaria:
Biogenix is one of India’s fastest emerging organization, setting a benchmark in In-Vitro Diagnostic (IVD) industry through its high quality accurate & responsive kits developed by highly qualified and experienced team for Research and Development. The commercial production takes place in a well-equipped, highly advanced automated plant established in Lucknow, Uttar Pradesh in the year 2017. During such short span Biogenix has followed all International norms and has been awarded with various National and International quality certifications like ISO, CE, and WHO/GMP etc. A constant process of Research and Development has allowed for more precise and improved Product quality to meet Indian as well as Global standards. Since its establishment, Biogenix has played a vital role in Screening and Prevention of Malaria through its Rapid Testing Kits for simultaneous detection and differentiation of Malaria Antigens.
This test is a qualitative, lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of Plasmodium falciparum (Pf) and vivax (Pv) antigen in human blood specimen.
Malaria Rapid Test Kit for Plasmodium falciparum (Pf) antigen and Plasmodium antigen (PAN) species [P. vivax (Pv), P. ovale (Po), or P. malariae (Pm)] Detection
This test is a qualitative, lateral flow immunoassay for the detection and differentiation of P. falciparum specific histidine rich protein-2 (Pf. HRP-2) and Pan specific aldolase from human whole blood samples.
Advantage of Rapid Testing Technique
Today, the malarial parasite invades countries, cities and towns across the world. Effective control and prevention. Choosing the appropriate Malaria test will guarantee the effective control and treatment of malarial parasite.
Prompt and accurate diagnosis like that obtained from using a Malaria Rapid test, followed by effective treatment is currently the main Malaria control strategy. This is essential to prevent the disease, death and further transmission of Malaria.
Our Malaria Rapid Tests play a major role in areas with health clinics that need to perform on-site field testing, and are also preferred by community health workers in areas where malaria microscopy is not always immediately available.
And in addition, an ever increasing population travelling to various tropical regions also return with Malarial parasite infections.
Comparison with Other Technologies
However, comparing to other advanced testing methodologies, like ELISA, PCR etc., the rapid testing techniques might fall short in terms of pin point accurate results, but as the on-field testing demands count on effectiveness and reliability of the test in quick screening of the disease at point of care applications, plain testing procedures and sample requirements, the rapid tests pounce ahead by providing all of this, also in an affordable test format.
Biogenix is pleased to offer the Malaria Rapid Tests in two formats: Malaria Pf & Pv Rapid Test and Malaria Pf & PAN Rapid tests. Our kits are tested and approved by ICMR-NIMR and are available in cassette format only.
For information about any of these Rapid Tests, ELISA Test Kits, Clinical Chemistry Kits, Serology Kits, or any other testing kit products of interest, please contact:
info@biogenix.in | info@biogenixinc.com
Comments
Post a Comment